FR2820035B1 - REDUCING COMPOSITION FOR THE TREATMENT OF KERATINIC MATERIAL COMPRISING A CATIONIC POLY (VINYLLACTAM) - Google Patents

REDUCING COMPOSITION FOR THE TREATMENT OF KERATINIC MATERIAL COMPRISING A CATIONIC POLY (VINYLLACTAM)

Info

Publication number
FR2820035B1
FR2820035B1 FR0101105A FR0101105A FR2820035B1 FR 2820035 B1 FR2820035 B1 FR 2820035B1 FR 0101105 A FR0101105 A FR 0101105A FR 0101105 A FR0101105 A FR 0101105A FR 2820035 B1 FR2820035 B1 FR 2820035B1
Authority
FR
France
Prior art keywords
vinyllactam
treatment
reducing composition
cationic poly
keratinic material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0101105A
Other languages
French (fr)
Other versions
FR2820035A1 (en
Inventor
Frederic Legrand
La Mettrie Rolland De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0101105A priority Critical patent/FR2820035B1/en
Priority to EP02700363A priority patent/EP1357891A1/en
Priority to PCT/FR2002/000254 priority patent/WO2002058661A1/en
Priority to CN 02800867 priority patent/CN1254227C/en
Publication of FR2820035A1 publication Critical patent/FR2820035A1/en
Application granted granted Critical
Publication of FR2820035B1 publication Critical patent/FR2820035B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
FR0101105A 2001-01-26 2001-01-26 REDUCING COMPOSITION FOR THE TREATMENT OF KERATINIC MATERIAL COMPRISING A CATIONIC POLY (VINYLLACTAM) Expired - Fee Related FR2820035B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0101105A FR2820035B1 (en) 2001-01-26 2001-01-26 REDUCING COMPOSITION FOR THE TREATMENT OF KERATINIC MATERIAL COMPRISING A CATIONIC POLY (VINYLLACTAM)
EP02700363A EP1357891A1 (en) 2001-01-26 2002-01-22 Reducing composition for treating keratinous materials comprising a cationic poly(vinyllactam)
PCT/FR2002/000254 WO2002058661A1 (en) 2001-01-26 2002-01-22 Reducing composition for treating keratinous materials comprising a cationic poly(vinyllactam)
CN 02800867 CN1254227C (en) 2001-01-26 2002-01-22 Reducing composition for treating keratinous materials comprising cationic poly (vinyllactam)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0101105A FR2820035B1 (en) 2001-01-26 2001-01-26 REDUCING COMPOSITION FOR THE TREATMENT OF KERATINIC MATERIAL COMPRISING A CATIONIC POLY (VINYLLACTAM)

Publications (2)

Publication Number Publication Date
FR2820035A1 FR2820035A1 (en) 2002-08-02
FR2820035B1 true FR2820035B1 (en) 2003-05-02

Family

ID=8859298

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0101105A Expired - Fee Related FR2820035B1 (en) 2001-01-26 2001-01-26 REDUCING COMPOSITION FOR THE TREATMENT OF KERATINIC MATERIAL COMPRISING A CATIONIC POLY (VINYLLACTAM)

Country Status (4)

Country Link
EP (1) EP1357891A1 (en)
CN (1) CN1254227C (en)
FR (1) FR2820035B1 (en)
WO (1) WO2002058661A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1019434A3 (en) 2010-07-23 2012-07-03 Auriga Internat STABILIZATION OF SULFORAPHANE.
WO2012027369A2 (en) * 2010-08-23 2012-03-01 Diversapack Of California, Llc System and method for straightening or shaping hair

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956430A (en) * 1989-05-01 1990-09-11 Gaf Chemicals Corporation Process for preparing substantially pure high molecular weight vinyl lactam-quaternized acrylamide copolymers
US6207778B1 (en) * 1999-05-07 2001-03-27 Isp Investments Inc. Conditioning/styling terpolymers

Also Published As

Publication number Publication date
WO2002058661A1 (en) 2002-08-01
FR2820035A1 (en) 2002-08-02
CN1254227C (en) 2006-05-03
CN1460016A (en) 2003-12-03
EP1357891A1 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
FR2831818B1 (en) OXIDIZING COMPOSITION FOR THE TREATMENT OF KERATINIC FIBERS COMPRISING A PARTICULAR AMINO SILICONE
FR17C1043I2 (en) NEW IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL MENINGITIS
IL194950A0 (en) Novel, arylsulfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
GB0221861D0 (en) Dispenser for personal care composition
HUP0401192A3 (en) Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds
HUP0002628A2 (en) Pharmaceutical combinations for treating diabetes
IL158590A0 (en) Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
BR0214263B1 (en) processes for the preparation of a hair care composition.
AP2003002907A0 (en) Liquid pharmaceutical composition.
FR2848428B1 (en) COSMETIC COMPOSITION AND PROCESS FOR THE TREATMENT OF KERATINIC MATERIALS, COMPRISING A PHOTODIMERIZABLE COMPOUND
FR2831817B1 (en) REDUCING COMPOSITION FOR THE TREATMENT OF KERATINIC FIBERS COMPRISING A PARTICULAR AMINO SILICONE
DE60133808D1 (en) ENGAGED LIQUID PARTICULAR RESISTANT WOMEN'S BANDS
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
MXPA03006629A (en) Skin care composition.
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
FR2831809B1 (en) OXIDIZING COMPOSITION FOR THE TREATMENT OF KERATINIC FIBERS COMPRISING A PARTICULAR AMINO SILICONE
PT1355906E (en) 2H-1-BENZOPYRANE DERIVATIVES PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS
PT1434588E (en) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino alkyl -acid derivatives for the treatment of pain
FR2820035B1 (en) REDUCING COMPOSITION FOR THE TREATMENT OF KERATINIC MATERIAL COMPRISING A CATIONIC POLY (VINYLLACTAM)
IL161748A0 (en) New use for the treatment of gastroesophageal reflux
FR2822645B1 (en) COMPOSITION FOR ENTERAL NUTRITION COMPRISING FIBERS
MXPA03007487A (en) Medicinal compositions comprising diclofenac and ornoprostil.
EP1435962A4 (en) Treatment of type i diabetes
AU2002360696A8 (en) Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
GB0212790D0 (en) Medicament for the treatment of diabetes

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070930